Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
4
Petroleo Brasileiro SA Petrobras
PBR
5
Ecopetrol
EC
US Stock MarketDetailed Quotes
IMMX Immix Biopharma
- 1.930
- +0.200+11.56%
Close Mar 18 16:00 ET
- 1.970
- +0.040+2.07%
Post 20:01 ET
53.09MMarket Cap-2.30P/E (TTM)
1.970High1.730Low83.79KVolume1.760Open1.730Pre Close158.14KTurnover0.47%Turnover RatioLossP/E (Static)27.51MShares3.35352wk High3.03P/B34.30MFloat Cap1.26052wk Low--Dividend TTM17.77MShs Float8.680Historical High--Div YieldTTM13.87%Amplitude0.680Historical Low1.887Avg Price1Lot Size
About Immix Biopharma Company
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Company Profile
SymbolIMMX
Company NameImmix Biopharma
Listing DateDec 16, 2021
Issue Price5.00
Founded2012
CEODr. Ilya Rachman
MarketNASDAQ
Employees17
Fiscal Year Ends12-31
Address11400 West Olympic Boulevard,Suite 200
CityLos Angeles
ProvinceCalifornia
CountryUnited States of America
Zip Code90064
Phone1-310-651-8041
Websitehttp://www.immixbio.com
Company Executives
- Name
- Position
- Salary
- Dr. Vladimir Torchilin
- Scientific Co-Founder
- --
- Dr. Ilya Rachman
- Chairman of the Board and Chief Executive Officer
- --
- Dr. Graham Ross
- Acting Chief Medical Officer and Head of Clinical Development
- --
- Gabriel Morris
- Chief Financial Officer, Principal Accounting Officer and Director
- --
- Jason Hsu
- Director
- --
- Helen C. Ada C.P.A.
- Independent Director
- --
- Yekaterina Chudnovsky
- Independent Director
- --
- Jane M. Buchan, PhD
- Independent Director
- --
- Dr. Magda Marquet, PhD
- Independent Director
- --
- Dr. Carey Ng
- Independent Director
- --
- Nandan Oza
- Head of Chemistry, Manufacturing, and Control
- --
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call